HEADER APOPTOSIS 11-SEP-13 4C5D TITLE CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND (42) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-26,83-209; COMPND 5 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX 6P3 KEYWDS APOPTOSIS, BCL-2 EXPDTA X-RAY DIFFRACTION AUTHOR M.J.ROY,R.M.BRADY,G.LESSENE,P.M.COLMAN,P.E.CZABOTAR REVDAT 3 20-DEC-23 4C5D 1 REMARK REVDAT 2 12-MAR-14 4C5D 1 JRNL REVDAT 1 05-FEB-14 4C5D 0 JRNL AUTH R.M.BRADY,A.VOM,M.J.ROY,N.TOOVEY,B.J.SMITH,R.M.MOSS,E.HAZIS, JRNL AUTH 2 D.C.S.HUANG,J.P.PARISOT,H.YANG,I.P.STREET,P.M.COLMAN, JRNL AUTH 3 P.E.CZABOTAR,J.B.BAELL,G.LESSENE JRNL TITL DE-NOVO DESIGNED LIBRARY OF BENZOYLUREAS AS INHIBITORS OF JRNL TITL 2 BCL-XL: SYNTHESIS, STRUCTURAL AND BIOCHEMICAL JRNL TITL 3 CHARACTERIZATION. JRNL REF J.MED.CHEM. V. 57 1323 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24456288 JRNL DOI 10.1021/JM401948B REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.13 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 14557 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.1334 - 3.9325 1.00 2930 140 0.1445 0.1943 REMARK 3 2 3.9325 - 3.1216 1.00 2761 156 0.1436 0.2331 REMARK 3 3 3.1216 - 2.7271 1.00 2744 159 0.1817 0.2979 REMARK 3 4 2.7271 - 2.4777 1.00 2704 151 0.2152 0.2656 REMARK 3 5 2.4777 - 2.3002 0.99 2666 146 0.2291 0.2937 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.330 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 2533 REMARK 3 ANGLE : 1.306 3412 REMARK 3 CHIRALITY : 0.077 340 REMARK 3 PLANARITY : 0.006 433 REMARK 3 DIHEDRAL : 16.619 882 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 0.6892 -20.8476 -32.4325 REMARK 3 T TENSOR REMARK 3 T11: 0.1503 T22: 0.1892 REMARK 3 T33: 0.2278 T12: -0.0148 REMARK 3 T13: -0.0201 T23: -0.0141 REMARK 3 L TENSOR REMARK 3 L11: 0.7210 L22: 0.4601 REMARK 3 L33: 2.8094 L12: 0.2364 REMARK 3 L13: -0.8664 L23: -0.3972 REMARK 3 S TENSOR REMARK 3 S11: -0.0332 S12: 0.0347 S13: -0.0680 REMARK 3 S21: 0.0036 S22: -0.0328 S23: -0.0212 REMARK 3 S31: 0.1329 S32: -0.1410 S33: 0.0688 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C5D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.956591 REMARK 200 MONOCHROMATOR : BEAMLINE OPTICS REMARK 200 OPTICS : BEAMLINE OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14561 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.600 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : 0.25000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.88 REMARK 200 R MERGE FOR SHELL (I) : 1.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.660 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C52 REMARK 200 REMARK 200 REMARK: LIGAND WAS REMOVED FROM STARTING MODEL FOR MOLECULAR REMARK 200 REPLACEMENT. INITIAL REFINEMENT INCLUDED ONE ROUND OF SIMULATED REMARK 200 ANNEALING. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1 M (NH4)2SO4, 0.1 M MES PH 6.5, 25% REMARK 280 (V/V) ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.25067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.12533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 44.12533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 88.25067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -210.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -44.12533 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2045 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 197 REMARK 465 ASN A 198 REMARK 465 ALA A 199 REMARK 465 ALA A 200 REMARK 465 ALA A 201 REMARK 465 GLU A 202 REMARK 465 SER A 203 REMARK 465 ARG A 204 REMARK 465 LYS A 205 REMARK 465 GLY A 206 REMARK 465 GLN A 207 REMARK 465 GLU A 208 REMARK 465 ARG A 209 REMARK 465 GLY B -5 REMARK 465 PRO B -4 REMARK 465 ALA B 199 REMARK 465 ALA B 200 REMARK 465 ALA B 201 REMARK 465 GLU B 202 REMARK 465 SER B 203 REMARK 465 ARG B 204 REMARK 465 LYS B 205 REMARK 465 GLY B 206 REMARK 465 GLN B 207 REMARK 465 GLU B 208 REMARK 465 ARG B 209 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 101 37.01 -95.16 REMARK 500 PHE A 105 44.93 -105.46 REMARK 500 TYR A 195 -86.07 -103.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X0R A 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X0R B 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1199 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1197 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1198 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1199 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C52 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND REMARK 900 (39B) DBREF 4C5D A 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4C5D A 83 209 UNP Q07817 B2CL1_HUMAN 83 209 DBREF 4C5D B 1 26 UNP Q07817 B2CL1_HUMAN 1 26 DBREF 4C5D B 83 209 UNP Q07817 B2CL1_HUMAN 83 209 SEQADV 4C5D GLY A -5 UNP Q07817 EXPRESSION TAG SEQADV 4C5D PRO A -4 UNP Q07817 EXPRESSION TAG SEQADV 4C5D LEU A -3 UNP Q07817 EXPRESSION TAG SEQADV 4C5D GLY A -2 UNP Q07817 EXPRESSION TAG SEQADV 4C5D SER A -1 UNP Q07817 EXPRESSION TAG SEQADV 4C5D GLY B -5 UNP Q07817 EXPRESSION TAG SEQADV 4C5D PRO B -4 UNP Q07817 EXPRESSION TAG SEQADV 4C5D LEU B -3 UNP Q07817 EXPRESSION TAG SEQADV 4C5D GLY B -2 UNP Q07817 EXPRESSION TAG SEQADV 4C5D SER B -1 UNP Q07817 EXPRESSION TAG SEQRES 1 A 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 A 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 A 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 A 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 A 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 A 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 A 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 A 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 A 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 A 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 A 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 A 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 A 158 GLU ARG SEQRES 1 B 158 GLY PRO LEU GLY SER MET SER GLN SER ASN ARG GLU LEU SEQRES 2 B 158 VAL VAL ASP PHE LEU SER TYR LYS LEU SER GLN LYS GLY SEQRES 3 B 158 TYR SER TRP SER GLN MET ALA ALA VAL LYS GLN ALA LEU SEQRES 4 B 158 ARG GLU ALA GLY ASP GLU PHE GLU LEU ARG TYR ARG ARG SEQRES 5 B 158 ALA PHE SER ASP LEU THR SER GLN LEU HIS ILE THR PRO SEQRES 6 B 158 GLY THR ALA TYR GLN SER PHE GLU GLN VAL VAL ASN GLU SEQRES 7 B 158 LEU PHE ARG ASP GLY VAL ASN TRP GLY ARG ILE VAL ALA SEQRES 8 B 158 PHE PHE SER PHE GLY GLY ALA LEU CYS VAL GLU SER VAL SEQRES 9 B 158 ASP LYS GLU MET GLN VAL LEU VAL SER ARG ILE ALA ALA SEQRES 10 B 158 TRP MET ALA THR TYR LEU ASN ASP HIS LEU GLU PRO TRP SEQRES 11 B 158 ILE GLN GLU ASN GLY GLY TRP ASP THR PHE VAL GLU LEU SEQRES 12 B 158 TYR GLY ASN ASN ALA ALA ALA GLU SER ARG LYS GLY GLN SEQRES 13 B 158 GLU ARG HET X0R A2000 39 HET SO4 A1197 5 HET SO4 A1198 5 HET SO4 A1199 5 HET EDO A1200 4 HET EDO A1201 4 HET EDO A1202 4 HET EDO A1203 4 HET EDO A1204 4 HET X0R B2000 39 HET SO4 B1199 5 HET SO4 B1200 5 HET SO4 B1201 5 HET EDO B1202 4 HET EDO B1203 4 HET EDO B1204 4 HET EDO B1205 4 HET EDO B1206 4 HETNAM X0R (R)-3-(4-BROMOBENZYLTHIO)-2-(3-(3-((2,4- HETNAM 2 X0R DIFLUOROPHENYL)ETHYNYL)BENZOYL)-3-PROPYLUREIDO) HETNAM 3 X0R PROPANOIC ACID HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 X0R 2(C29 H25 BR F2 N2 O4 S) FORMUL 4 SO4 6(O4 S 2-) FORMUL 7 EDO 10(C2 H6 O2) FORMUL 21 HOH *101(H2 O) HELIX 1 1 SER A 4 GLN A 19 1 16 HELIX 2 2 SER A 25 TYR A 101 1 21 HELIX 3 3 ARG A 102 PHE A 105 5 4 HELIX 4 4 ASP A 107 LEU A 112 1 6 HELIX 5 5 ALA A 119 PHE A 131 1 13 HELIX 6 6 ASN A 136 LYS A 157 1 22 HELIX 7 7 VAL A 161 LEU A 178 1 18 HELIX 8 8 LEU A 178 ASN A 185 1 8 HELIX 9 9 GLY A 187 TYR A 195 1 9 HELIX 10 10 SER B -1 GLN B 19 1 20 HELIX 11 11 SER B 25 ARG B 102 1 22 HELIX 12 12 ARG B 103 SER B 106 5 4 HELIX 13 13 LEU B 108 HIS B 113 1 6 HELIX 14 14 ALA B 119 PHE B 131 1 13 HELIX 15 15 ASN B 136 LYS B 157 1 22 HELIX 16 16 GLN B 160 HIS B 177 1 18 HELIX 17 17 HIS B 177 ASN B 185 1 9 HELIX 18 18 GLY B 186 GLY B 196 1 11 SITE 1 AC1 12 PHE A 97 GLN A 111 LEU A 112 PHE A 123 SITE 2 AC1 12 VAL A 126 LEU A 130 ARG A 139 PHE A 143 SITE 3 AC1 12 PHE A 146 GLY A 147 LEU A 150 MET A 170 SITE 1 AC2 16 LEU A 99 ARG A 102 PHE B 97 TYR B 101 SITE 2 AC2 16 ARG B 103 ALA B 104 GLN B 111 PHE B 123 SITE 3 AC2 16 VAL B 126 LEU B 130 ARG B 139 PHE B 143 SITE 4 AC2 16 PHE B 146 GLY B 147 MET B 170 HOH B2031 SITE 1 AC3 3 ASN B 136 ARG B 139 HOH B2027 SITE 1 AC4 7 SER A -1 GLY A -2 GLU A 7 HOH A2003 SITE 2 AC4 7 TRP B 24 SER B 25 EDO B1202 SITE 1 AC5 3 ASN A 136 ARG A 139 HOH A2043 SITE 1 AC6 4 ASN B 136 TRP B 137 GLY B 138 HOH B2029 SITE 1 AC7 6 ARG A 6 VAL A 10 TRP A 24 SO4 A1199 SITE 2 AC7 6 MET B 1 SER B 2 SITE 1 AC8 7 TRP A 24 SER A 25 MET A 83 HOH A2024 SITE 2 AC8 7 SER B -1 MET B 1 SO4 B1201 SITE 1 AC9 7 THR A 115 PRO A 116 HOH A2033 ASN B 128 SITE 2 AC9 7 PHE B 131 TYR B 173 HIS B 177 SITE 1 BC1 5 ASP A 11 ARG A 91 GLN B 88 ARG B 91 SITE 2 BC1 5 EDO B1202 SITE 1 BC2 4 SO4 A1197 EDO A1201 SER B 14 LYS B 87 SITE 1 BC3 5 TYR B 15 GLN B 19 THR B 109 HIS B 113 SITE 2 BC3 5 THR B 115 SITE 1 BC4 2 ARG B 100 ARG B 103 SITE 1 BC5 2 TYR B 120 TRP B 169 SITE 1 BC6 5 GLN A 88 ARG A 91 HOH A2025 TYR B 15 SITE 2 BC6 5 ARG B 91 SITE 1 BC7 4 ASN A 136 TRP A 137 GLY A 138 TYR A 195 SITE 1 BC8 4 SER A 14 ARG A 91 ASP B 11 ARG B 91 SITE 1 BC9 4 ASN A 128 VAL A 135 TYR A 173 HIS A 177 CRYST1 64.138 64.138 132.376 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015591 0.009002 0.000000 0.00000 SCALE2 0.000000 0.018003 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007554 0.00000